IrtemazoleAlternative Names: R 60844
Latest Information Update: 17 Feb 1995
At a glance
- Originator Janssen L.P.
- Class Benzimidazoles; Small molecules; Uricosurics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gout
Most Recent Events
- 17 Feb 1995 Discontinued-I for Gout in Germany (Unknown route)
- 17 Feb 1995 Discontinued-II for Gout in Belgium (Unknown route)